Mechanism of Action of Niacin

2008/04/01 by Vaijinath S. Kamanna, Moti L. Kashyap · 28 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Diabetes, Cardiovascular Risks, and Lipoproteins #Peroxisome Proliferator-Activated Receptors #Lipid metabolism and biosynthesis

paper · doi:10.1016/j.amjcard.2008.02.029

Cited by

• Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy
• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
• The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
• FoxO1 integrates insulin signaling to VLDL production. [europepmc]
• The importance of NAD in multiple sclerosis. [europepmc]
• Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. [europepmc]
• The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). [europepmc]
• Triglycerides and heart disease: still a hypothesis? [europepmc]
• The role of triglycerides in atherosclerosis. [europepmc]
• The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. [europepmc]
• Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? [europepmc]
• NAD+ as a signaling molecule modulating metabolism. [europepmc]
• Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress. [europepmc]
• Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells. [europepmc]
• Neurorestorative therapy for stroke. [europepmc]
• Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases. [europepmc]
• Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back. [europepmc]
• Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. [europepmc]
• Metabolomics activity screening for identifying metabolites that modulate phenotype. [europepmc]
• Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. [europepmc]
• Targeting the gut barrier for the treatment of alcoholic liver disease. [europepmc]
• Role of endothelial NAD + deficiency in age-related vascular dysfunction. [europepmc]
• Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. [europepmc]
• The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. [europepmc]
• What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis. [europepmc]
• Current Applications of Liposomes for the Delivery of Vitamins: A Systematic Review. [europepmc]
• Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease. [europepmc]
• Functional significance of cholesterol metabolism in cancer: from threat to treatment. [europepmc]